期刊文献+

HB—H-8树脂吸附低密度脂蛋白的体外实验研究 被引量:1

In vitro experimental study on removing low density lipoprotein with HB-H-8 resin adsorption
原文传递
导出
摘要 目的目前,用于降低血液中低密度脂蛋白(LDL)的吸附分离材料尚存在需要改进的地方。HB-H-8树脂在吸附LDL方面尚无应用,本研究对HB-H-8树脂的吸附性能进行了初步评价。方法首先实验室制备HB-H-8树脂,经过处理后用其对LDL高于正常范围的患者血清标本进行体外动态和静态吸附实验。结果体外动态吸附结果表明,HB-H-8树脂对LDL的吸附饱和时间为2h,最适吸附温度为恒温37℃,体外静态吸附结果显示HB-H-8树脂对LDL平均吸附率为63.2%,而对高密度脂蛋白(HDL)的平均吸附率为1.9%。结论HB-H-8树脂对LDL具有良好的特异性吸附性能,有望开发为一种低密度脂蛋白的血液净化医用吸附材料。 Objective Currently, adsorption materials applied to remove low density lipoprotein (LDL) still remain defects. HB-H-8 resin has not been put in use in removing LDL. This study focused on primary evaluation of adsorption capability of HB-H-8 resin. Methods HB-H-8 resin was used in the adsorption of LDL of patient that was higher than the normal range of blood sample in dynamic test and static test in vitro. Results The time of adsorption saturation was two hours, and the optimum temperature was 37 ℃. The results of adsorption in vitro showed that the average adsorption rates of LDL and high density lipoprotein (HDL) were 63.2% and 1.9%, respectively. Conclusion HB-H-8 resin has LDL higher adsorption capability, thus made it to be a potential blood purification material for the removal of LDL.
出处 《国际生物医学工程杂志》 CAS 2012年第2期121-124,共4页 International Journal of Biomedical Engineering
关键词 低密度脂蛋白 高密度脂蛋白 血浆灌流 吸附 Low density lipoprotein High density lipoprotein Hemoperfusion Adsorption
  • 相关文献

参考文献18

  • 1张迎庆,干信,谢笔钧.低密度脂蛋白血液净化研究进展[J].药物生物技术,2004,11(2):116-120. 被引量:8
  • 2Reimann M, Julius U, Haink K, et al. LDL apheresis improves de- ranged cardiovagal modulation in hypercholesterolemic patients [J]. Atherosclerosis, 2010, 213(1): 212-217.
  • 3Moriarty PM. LDL-apheresis therapy: current therapeutic practice and potential future use[J]. Future Med, 2006, 1(3): 299-308.
  • 4Hu Gang, Cui Ya-dong, Jousilahti P, et al. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease[J]. Eur J Cardiovasc Prey Rehabil, 2011.
  • 5Masaru N, Akira R, Takehiro N, et al. Low density lipoprotein/fib- rinogen adsorbent and adsorption apparatus capable of whole blood treatment: US, 20060089587[P]. 2006-04-27.
  • 6Chen Shun-jie, Jiang Geng-ru, Shan Jian-ping, et al. Combination of maintenance hemodialysis with hemoperfusion: a safe and effective model of artificial kidney[J]. Int J Artif Organs, 2011, 34(4): 339-347.
  • 7党英萍,蔡绍皙,麻开旺.一种LDL选择性吸附剂的制备及其血液相容性研究[J].中国医学物理学杂志,2007,24(6):435-439. 被引量:5
  • 8Malleshappa P, Ranganath R, Chaudhari AP, et al. Effective use of polymyxin B hemoperfusion in septic shock complicated by urosep- sis[J]. Indian J Nephrol, 2011, 21(1): 41-43.
  • 9Masin V, Blaha M, Stransky P, et al. Optimization of therapeutic procedure during LDL-apheresis-verification of the computerized model in clinical practice[J]. Transfus Apher Sci, 2007, 36(1): 39-45.
  • 10丁勇.大孔树脂对脂蛋白的吸附研究[J].食品科学,2010,31(1):76-78. 被引量:1

二级参考文献66

  • 1郭贤权,陈政,喻文欣,何炳林,陈东昇,初进,李翠兰,高晓峰.三种新型吸附剂的合成、改性及性能研究[J].离子交换与吸附,1994,10(1):1-6. 被引量:3
  • 2CORNELIUS R M, ARCHAMBAULT J, BRASH J L. Identification of apolipoprotein A-I as a major adsorbate on biomaterial surfaces after blood or plasma contact[J]. Biomaterials, 2002, 23: 3583-3587.
  • 3BOSCH T. Practical aspects of direct adsorption of lipoproteins from whole blood by DALI LDL-aplaeresis[J]. Transfusion and Apheresis Science, 2004, 31: 83-88.
  • 4THOMPSON G R. LDL apheresis[J]. Atherosclerosis, 2003, 167: 1-13.
  • 5WANG Y, WALLI A K, SCHULZE A, et al. Heparin-mediated extracor- poreal low density lipoprotein precipitation as a possible therapeutic approach in preeclampsia[J]. Transfusion and Apheresis Science, 2006, 35(2): 103-110.
  • 6CHENG Y, WANG S Q, YU Y T, et al. In vitro, in vivo studies of a new arnphiphilic adsorbent for the removal of low-density lipoprotein[J]. Biomaterials, 2003, 24(13): 2189-2194.
  • 7Allkson TG, Squires RW, Johnson BD, et al, Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet.exercise, weight control, and drug therapy[J]. Mayo Clin Proc , 1999,74,466.
  • 8CShepherd J, Cobbe SM, Ford I, et al. West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia[J]. N Eng J Med, 1995, 333; 1301.
  • 9Thompson GR, Lowenthal R, Myant NB. Plasma exchange in the management of homozygous familial hypercholesterolaemia[J]. Lancet, 1975,1 : 1208.
  • 10Apstein CS, Zilversmit DB, Lees RS, et al. Effect of instensire plasmapheresis on the plasma cholesterol concentration with familial hypercholesterolemia [J]. Atherosclerosis,1978, 31:108.

共引文献26

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部